Business
Cytophage Launches Ready-to-Use Lyophilized Phage Tablets to Improve Gut Health in Poultry
(TheNewswire) Winnipeg – TheNewswire - August 15 2024 - Cytophage Te...
About this update from Cytophage Technologies Ltd.
[{"type":"text","content":"Cytophage Launches Ready-to-Use Lyophilized Phage Tablets to Improve Gut Health in Poultry\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Winnipeg –\n \n\n TheNewswire\n-\n \n\n August 15 2024\n \n\n -\n \n\n Cytophage Technologies Ltd.\n(\n \n\n TSXV:CYTO\n \n\n ) (“\n \n\n Cytophage\n \n\n ” or the “\n \n\n Company\n \n\n ”),\n \n\n\n the only publicly traded phage company\nthat is focused on bacteriophage solutions for both animal health and\nhuman health, is pleased to announce the launch of a simplified\napplication option for bacteriophages that can treat multiple types of\nbacteria, such as\n \n\n\n E.\ncoli\n \n\n and\n \n\n Salmonella\n \n\n\n ,\nthroughout the lifecycle of a chicken. The lyophilized tablets were\nfirst developed and tested in the spring of 2024 and are now being\ntargeted for wider application.\n \n\n\n\n\n\n The lyophilized phage tablets are designed to provide an alternative\nto the liquid form commonly used in phage therapy. This lyophilized\n(freeze-dried/stabilized) product represents a technological\nbreakthrough, offering increased flexibility, stability, and\napplication versatility.  This innovative development is in direct\nresponse to Cytophage working with the poultry industry on phage\nproducts with the goal to reduce the use of broad-spectrum antibiotics\nand replace them with targeted phages.\n \n\n\n\n\n Product Highlights:\n \n\n\n\n\n\n\n Ready-to-use, dissolves easily in water to simplify the process for\nthe farmer.\n \n\n\n\n\n\n\n Dose controlled, can simply be added to the specified\nwater levels (see Image 1).\n \n\n\n\n\n\n Temperature stable, does not require a cold chain\nmaking it easily usable in hotter climates such as South-East Asia.\n \n\n\n\n\n\n Lightweight packaging, easily portable to the\nbarn.\n \n\n\n\n\n\n Cytophage CEO, Dr. Steven Theriault, commented: ”The\nimportance of eliminating the need for a cold chain cannot be\noverstated. Offering phages in lyophilized form represents a\ncompetitive advantage over other phage producers who have only liquid\nproducts that require refrigeration. Our innovative manufacturing\nincreases our products’ heat tolerance and shelf-life.”\n \n\n\n\n\n\n\n\n\n\n Image 1: Lyophilized phage tablets easily dissolve in the specified\nwa...